Net loss of Kwality Pharmaceuticals reported to Rs 7.38 crore in the quarter ended March 2023 as against net profit of Rs 10.50 crore during the previous quarter ended March 2022. Sales rose 7.42% to Rs 68.80 crore in the quarter ended March 2023 as against Rs 64.05 crore during the previous quarter ended March 2022.

For the full year,net profit declined 83.86% to Rs 19.37 crore in the year ended March 2023 as against Rs 119.99 crore during the previous year ended March 2022. Sales declined 44.97% to Rs 251.03 crore in the year ended March 2023 as against Rs 456.19 crore during the previous year ended March 2022.

Powered by Capital Market - Live News

Net loss of Kwality Pharmaceuticals reported to Rs 7.36 crore in the quarter ended March 2023 as against net profit of Rs 10.51 crore during the previous quarter ended March 2022. Sales rose 7.43% to Rs 68.80 crore in the quarter ended March 2023 as against Rs 64.04 crore during the previous quarter ended March 2022.

For the full year,net profit declined 83.78% to Rs 19.47 crore in the year ended March 2023 as against Rs 120.05 crore during the previous year ended March 2022. Sales declined 44.97% to Rs 250.99 crore in the year ended March 2023 as against Rs 456.13 crore during the previous year ended March 2022.

Powered by Capital Market - Live News

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 May 2023.

Powered by Capital Market - Live News

Net profit of Kwality Pharmaceuticals declined 55.26% to Rs 7.10 crore in the quarter ended December 2022 as against Rs 15.87 crore during the previous quarter ended December 2021. Sales declined 36.27% to Rs 56.20 crore in the quarter ended December 2022 as against Rs 88.19 crore during the previous quarter ended December 2021.

Powered by Capital Market - Live News